Furthermore, we observed the presence of tertiary lymphoid structures within the tumor from mice treated with “BC@Z-M + L”, characterized by a distinct CD20+ B cell adjacent to a CD4+ and CD8+ T cell zone (Supplementary Fig. 63). The gene discussed is CD8A; the disease is breast cancer.